HIGHLIGHTS
- who: CSCs et al. from the Hokkaido University, Japan have published the Article: Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells, in the Journal: (JOURNAL)
- what: This study provided new ideas for the cost- be plastic, and differentiate as required.
- how: The experimental data are presented as mean u00b1 standard deviation (SD). Showed that the proportion of positive cells in the bevacizumab and cisplatin groups was significantly increased compared with the control group.
- future . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.